Maastrich II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori

World Journal of Gastroenterology

Volumn 10, Issue 11, 2004, Pages 1656-1658

  Altintas, Engin ^a   Sezgin, Orhan ^a   Ulu, Oguz ^a   Aydin, Ozlem ^a   Camdeviren, Handan ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; UREASE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; ENZYME INHIBITOR; PROTON PUMP;

ADULT; ARTICLE; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; ENZYME ANALYSIS; EPIGASTRIC PAIN; FEMALE; GASTROINTESTINAL DISEASE; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOMES RESEARCH; PAIN; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RANDOMIZATION; RATING SCALE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; VOMITING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; TREATMENT OUTCOME;

EID: 2942735446     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i11.1656     Document Type: Article

References (31)

1. Fennerty MB. What are the treatment goals for helicobacter pylori infection? Gastroenterology 1997; 113 (Suppl): S120-125
2. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. European Helicobacter pylori Study Group (EHPSG). Current concepts in the management of helicobacter pylori infection-The Maastricht 2-2 000 Consensus report. Aliment Pharmacol Ther 2002; 16: 167-180
3. Herrerias JM, Bujanda L, Pena D. Efficacy and cost study in Portugal and Spain of three different 7 day eradication regimens of Helicobacter pylori. Gastroenterology 1999; 116: A186
4. Spinzi GC, Bortoli A, Corbellini A. One week therapy with omeprazole (PPÝ) or ranitidine bismuth citrate (RBC) and two antibiotics for the eradication of Helicobacter pylori in duodenal ulcer: a preliminary report. Gastroenterolgy 1998; 116: A294
5. Sung JY, Leung WK, Ling TK, Yung MY, Chan FK, Lee YT, Cheng AF, Chung SC. One week use of ranitidine bismuth citrate, amoxicillin and claritromycin for the treatment of Helicobacter pylori related duodenal ulcer. Aliment Pharmacol Ther 1998; 12: 723-730
6. Susi D. The best treatment for Helicobacter pylori infection among for different 7 day triple therapies. Gut 1998; 43 (Suppl 2): A80
7. Peura DA. The report of the digestive health initiative international update conference on Helicobacter pylori. Gastroenterology 1997; 113: 4-8
8. Chey WD. Treating Helicobacter pylori: candidate and regimen selection. Contemp 1997; 9: 52-61
9. Pounder RE. New developments in H pylori eradication therapy. Scand J Gastroenterol 1997; 32 (suppl): 43-45
10. The European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 8-13
11. Forne M, Viver JM, Esteve M, Fernandez-Banares F, Lite J, Quintana S, Salas A, Garau J. Randomized clinical trial comparing two one week triple therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing. Am J Gastroenterol 1998; 93: 35-38
12. Delchier JC, Elamine I, Goldfain D, Chaussade S, Barthelemy P, Idstrom JP. Omeprazole-amoxicillin v̀ersus omeprazole-amoxicillin-clarithtomycin in the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1995; 10: 263-268
13. Scwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J. Triple versus dual therapy eradication of Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithyromycin, and/or amoxicillin in different dosing regimens. Am J Gastroenterol 1998; 93: 584-590
14. Ergün Y, Abayli B, Öksüz M. Helikobakter pilori pozitif kronik aktif gastritli hastalarda degisik iki tedavi protokolünün etkinligi. Turk J Gastroenterol 2002; 13(Suppl 1 ): 86
15. Bölükbasi F, Kiliç H, Bölükbasi C. Helikobakter pilori eradikasyonu sonrasi reflü üzefajit sikligi. Turk J Gastroenterol 2001; 12(Suppl 1): 87
16. Bölükbasi F, Kiliç H, Bölükbasi C. Helikobakter pilori eradikasyon tedavisinde eradikasyon oranlari ve tedavi süresinin bu oranlara etkisi. Turk J Gastroenterol 2001; 12(Suppl 1): 88
17. Sotoudehmanesh R, Malekzadeh R, Vahedi H, Dariani NE, Asgari AA, Massarrat S. Second-line Helicobacter pylori eradication with a furazolidon-based regimen in patients who have failed a metranidazole-based regimen. Digestion 2001; 64: 222-225
18. Tursi A, Cammarato G, Montalto M, Papa A, Veneto G, Cuoco L, Trua F, Branca G, Fedeli G, Gasbarrini G. Low-dose omeprazole plus clariythromycin and either tinidazole or amoxicillin for Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 285-288
19. Spinzi GC, Bierty L, Bortoli A, Colombo E, Fertitta AM, Lanzi GL, Venturelli R, Minoli G. Comparison of omeprazole and lansoprazole in short term triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998; 12: 433-438
20. Catalano F, Catanzaro R, Bentivegna C, Brogna A, Condorelli G, Cipolla R. Ranitidine bismuth citrate versus omeprazole triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998; 12: 59-62
21. Rinaldi V, Zullu A, De Francesco V, Hassan C, Winn S, Stoppino V, Faleo D, Attili AF. H pylori eradication with proton pomp inhibitor based triple therapies and re-treatment with ranitidine bismuth citrate based triple therapy. Aliment Pharmacol Ther 1999; 13: 163-168
22. Deltenre M, Jonas C, van Gossum M, Buset M, Otero J, De Koster E. Omeprazole-based antimicrobial thérapies: results in 198 H pylori positive patients. Eur J Gastroenterol Hepatol 1995; 7(Suppl 1): 39-44
23. Labenz J, Stolte M, Peitz U, Tillenburg B, Becker T, Borsch G. One-week triple therapy with omeprazole, amoxicillin and clarithromycin or metranidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 207-210
24. Biggard MA, Delchier JC, Riachi G, Thibault P, Barthelemy P. One week triple therapy using omeprazole, amoxicillin and clarithromycin for the eradication of Helicobacter pylori infection in patients with non-ulcer dyspepsia: influence of dosage of amoxicillin and clarithromycin. Aliment Pharmacol Ther 1998; 12: 383-388
25. Özaslan E, Balaban G, Tatar H. Helikobakter pilori eradikasyonunda en yaygin kullanilan LAK protokolünün baparisi azaliyor mu? Turk J Gastroenterol 2001; 12(Suppl 1):93
26. Bazzoli F, Zagari M, Pozzato P, Varoli O, Fossi S, Ricciardiello L, Alampi G, Nicolini G, Sottili S, Simoni P, Roda A, Roda E. Evaluation of short term low dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study. Aliment Pharmacol Ther 1998; 12: 439-445
27. Huang JQ, Hunt RH. Treatment failure: the problem of non-responders. Gut 1999; 45(Suppl): 140-144
28. Tankowic J, Lamarque D, Lascols C, Soussy CJ, Delchier JC. The impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy. Aliment Pharmacol Ther 2001; 15: 707-713
29. Schimd CH, Ross SD, Witing GW. Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: a meta regression. Gut 1996; 39(Suppl 2): A37
30. Kamada T, Haruma K, Komoto K, Mihara M, Chen X, Yoshihara M, Sumii K, Kajiyama G, Tahara K, Kawamura Y. Effect of smoking and histological gastritis severity on the rate of Helicobacter pylori eradication with omeprazole, amoxicillin and clarithromycin. Helicobacter 1999; 4: 204-210
31. Georgopoulos SD, Ladas SD, Karatapanis S, Mentis A, Spiliadi C, Artikis V, Raptis SA. Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin. Dig Dis Sci 2000; 45: 63-67